Hematology
Loretta Nastoupil, M.D.
Associate Professor, Director of the Lymphoma Outcomes Database, and Section Chief of New Drug Development, Department of Lymphoma and Myeloma
Loretta J. Nastoupil, M.D., is an associate professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center in Houston, Texas, where she serves as Director of the Lymphoma Outcomes Database and Section Chief of New Drug Development. She specializes in hematologic oncology, with a primary focus on lymphomas including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and multiple myeloma. Dr. Nastoupil treats patients with relapsed or refractory B
19+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
- Internal Medicine (American Board of Internal Medicine)
Education & Training
- Emory University School of Medicine — Fellowship, Hematology and Medical Oncology, 2010-2013
- Washington University/B-JH/SLCH Consortium — Residency, Internal Medicine, 2007-2010
- University of Texas Southwestern Medical School — M.D., 2007
Peer Recognition
- CMS — Meaningful Use Stage 1 Certification
2014-2015 (2 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- University of Texas MD Anderson Cancer Center
Languages
English[1]
Experience
19+ years in practice